In the coming years, North America is poised to maintain its prominent position as a key player in the Non-Small Cell Lung Carcinoma NSCLC Industry, solidifying its status as one of the most lucrative regions. This dominance is underpinned by the region’s robust pipeline and extensive research endeavors by both industry stakeholders and academic institutions. …